ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Significance of DSA Clearance in Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients on 1 Year Outcomes: Interim Results from PARAMOUr “Pediatric Renal AMr Outcomes” Study

    I. Ashoor1, R. Garro2, S. Solomon3, A. Jain4, M. Kallash5, K. Twombley6

    1LSHUSC Children's Hospital New Orleans, New Orleans, LA, 2Emory University School of Medicine, Atlanta, GA, 3New York Medical College, Valhalla, NY, 4Wayne State University School of Medicine, Detroit, MI, 5Nation Wide Children's Hospital, Columbus, OH, 6Medical University of South Carolina, Charleston, SC

    *Purpose: Little is known about how donor specific antibody (DSA) clearance correlates with outcomes in pediatric antibody mediated rejection (AMR). There is also little data…
  • 2020 American Transplant Congress

    Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation

    J. A. Reyes, C. Blanton, M. Eerhart, G. Leverson, P. Chlebeck, Y. Yankol, L. Fernandez

    Surgery, University of Wisconsin, Madison, WI

    *Purpose: End-stage renal disease (ESRD) frequently develops after nonrenal solid-organ transplantation, increasing the number of patients with a prior heart, liver or lung transplant on…
  • 2020 American Transplant Congress

    Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension

    F. Al Ammary1, S. Yu2, A. Muzaale2, L. Luckmini2, D. C. Crews1, D. Brennan1, D. Segev2, A. B. Massie2

    1Medicine, Johns Hopkins, Baltimore, MD, 2Surgery, Johns Hopkins, Baltimore, MD

    *Purpose: Allografts from living kidney donors may “carry” subclinical pathological abnormalities to the recipient and thus lead to adverse clinical outcomes. Because one mechanism underlying…
  • 2020 American Transplant Congress

    The Safety and Efficacy of 6-Month Steroid Reduction Strategy after Kidney Transplantation: A Prospective Cohort Study

    J. Bang, C. Oh, S. Lee

    Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of

    *Purpose: In kidney transplantation, immunosuppressive regimens almost always contain corticosteroids for preventing acute rejection and graft loss. However, long-term maintenance of corticosteroids has been associated…
  • 2020 American Transplant Congress

    Serum Cystatin C Predicts Kidney-Related Outcomes and Transplant-Free Survival in Patients with End-Stage Liver Disease and Low Body Mass Index

    N. Shankar1, M. Garcia Saenz de Sicilia2, A. Duarte-Rojo3, S. K. Asrani4, J. F. Trotter4, G. B. Klintmalm4, B. V. Fischbach5, S. A. Gonzalez5

    1Internal Medicine, Baylor Scott & White University Medical Center, Dallas, TX, 2University of Arkansas for Medical Sciences, Little Rock, AR, 3Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Baylor Simmons Transplant Institute, Dallas, TX, 5Baylor Simmons Transplant Institute, Fort Worth, TX

    *Purpose: Liver transplant (LT) candidates with sarcopenia are disadvantaged by creatinine-based assessment of renal function as creatinine overestimates glomerular filtration rate (GFR). Low body mass…
  • 2020 American Transplant Congress

    Adult Split Liver Transplants Increased after Implementation of a Pediatric Liver Transplant Program

    J. Cullen1, P. Vargas1, S. Pelletier1, K. Soltys2, S. Rasmussen1, G. Mazariegos2, J. Oberholzer1, N. Goldaracena1

    1Surgery, University of Virginia, Charlottesville, VA, 2Surgery, University of Pittsburgh, Pittsburgh, PA

    *Purpose: Split liver transplantation (SLT) is a strategy to address organ shortage, but is technically more demanding than whole liver transplants.*Methods: SLTs conducted at a…
  • 2020 American Transplant Congress

    Transplant Center Effect on Acute Liver Failure Outcomes in a National Cohort

    N. Z. Wong, K. R. Reddy, T. Bittermann

    University of Pennsylvania, Philadelphia, PA

    *Purpose: Transplant centers coordinate complex care for patients with acute liver failure (ALF), in whom liver transplantation (LT) can be lifesaving. This study examines associations…
  • 2020 American Transplant Congress

    Pneumocystis Pneumonia Occurrence and Prophylaxis Duration in Kidney Transplant Recipients According to Perioperative Treatment with Rituximab

    Y. Ko, Y. Kim, D. Han, H. Kwon

    Department of Surgery, Division of Kidney and Pancreas Transplant, AMC, Seoul, Korea, Republic of

    *Purpose: Pneumocystis pneumonia (PCP) is a life-threatening fungal infection that can occur in kidney transplantation (KT) recipients. A growing number of KT recipients are receiving…
  • 2020 American Transplant Congress

    Glecaprevir-Pibrentasvir Effect on Tacrolimus Troughs in Abdominal Transplant Recipients

    M. Chunduru, K. Schnelle, H. Winters, O. Witkowsky, L. Von Stein

    The Ohio State Wexner Medical Center, Columbus, OH

    *Purpose: Glecaprevir-pibrentasvir (GP) is one of several pangenotypic therapies available for the treatment of hepatitis C. Historical use of ritonavir based hepatitis C therapies increased…
  • 2020 American Transplant Congress

    The 1-Year Incremental Costs of Delayed Graft Function (DGF) in Commercially Insured Kidney Transplant Patients Under 65

    T. Mayne1, F. Corvino2, A. Dillon2, W. Wang2, S. Mohan3

    1Angion Biomedica Corp, San Francisco, CA, 2Genesis Research, Hoboken, NJ, 3Columbia University Medical Center, New York, NY

    *Purpose: Strong evidence exists that DGF is associated with poor patient outcomes. The long-term impact of DGF on health resource use and cost, however, is…
  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences